Fukuoka, Japan · Founded 2015 · Privately Held (backing)
Operator of a biopharmaceutical company intended to deliver cancer immuno-cell therapy. GAIA BioMedicine is based in Fukuoka, Japan and was founded in 2015. Its last reported valuation was $88.4 million in Jul 2025. It has raised $37.6 million.
Last reported valuation
$88.4M
Oct 2026
Priced at
—
Total raised
$37.6M
Last round
—
Cap table — not yet on record
GAIA BioMedicine's share-class structure hasn't surfaced in our sources yet. Cap tables are assembled from certificates of incorporation, round filings, and disclosures as they land.
Pro members can request priority coverage with a 48-hour turnaround.
Private Market View
More of GAIA BioMedicine with a free Private Market View account
·Watch GAIA BioMedicine: the Monday email on marks, rounds and moves
